New Study on Autism Spectrum Disorder and Cannabis Leave a comment Medical, National News, Studies May 5, 2021 May 10, 2021 Neurotech International Limited (ASX:NTI) is opening a clinical study trial in 20 children aged between 5-17 years, who have Autism Spectrum Disorder (ASD). READ ARTICLE Related Posts:Cannabis Use Disorder on the Rise for Pregnant WomenIs CBD a Universal Solution? The Verdict is Still…Can medical cannabis help children with autism in Australia?Is it permissible to utilize medicinal cannabis for…Exciting News: Cannabis Extracts Could Improve Life…US Study on Why Those Who Exercise Are Using Cannabis
